Hepatic Granulomas: Pathogenesis and Differential Diagnosis

Clinics in Liver Disease

Volumn 14, Issue 4, 2010, Pages 605-617

  Lagana, Stephen M ^a   Moreira, Roger K ^a   Lefkowitch, Jay H ^b  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Granulomatous hepatitis; Hepatic granuloma; Primary biliary cirrhosis; Sarcoidosis

Indexed keywords

ALLOPURINOL; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BCG VACCINE; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CEFALEXIN; CHLORPROMAZINE; CONTRACEPTIVE AGENT; DAPSONE; DIAZEPAM; ETANERCEPT; EXCEDRIN; FEPRAZONE; HALOTHANE; HERBACEOUS AGENT; ISONIAZID; METHYLDOPA; MINERAL OIL; NITROFURANTOIN; OXACILLIN; PAPAVERINE; PARACETAMOL; PHENYTOIN; PROPYLTHIOURACIL; QUININE; RANITIDINE; SARIDON; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACTINOMYCOSIS; ADVERSE OUTCOME; ASPERGILLOSIS; AUTOIMMUNE HEPATITIS; BARTONELLOSIS; BUDD CHIARI SYNDROME; CANCER INCIDENCE; CANCER PATIENT; CANDIDIASIS; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COCCIDIOIDOMYCOSIS; CROHN DISEASE; CYTOKINE RESPONSE; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG OVERDOSE; EPSTEIN BARR VIRUS INFECTION; FOREIGN BODY; GASTROINTESTINAL CARCINOMA; HEPATITIS B; HEPATITIS C; HISTOPLASMOSIS; HODGKIN DISEASE; HUMAN; INTESTINE LIPODYSTROPHY; LEUKEMIA; LISTERIOSIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER GRANULOMA; LIVER TOXICITY; LYME DISEASE; MOLECULAR BIOLOGY; MUCORMYCOSIS; NOCARDIOSIS; PARASITOSIS; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PROTOZOAL INFECTION; REGULATORY T LYMPHOCYTE; REVIEW; RICKETTSIACEAE INFECTION; SALMONELLOSIS; SARCOIDOSIS; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; TOXOPLASMOSIS; TUBERCULOSIS; TULAREMIA; TUMOR IMMUNITY; TYPHOID FEVER; WEGENER GRANULOMATOSIS; YERSINIA INFECTION;

DIAGNOSIS, DIFFERENTIAL; GRANULOMA; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; SARCOIDOSIS;

EID: 78049478202     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.07.005     Document Type: Review

References (61)

1. Zaba L.C., Smith G.P., Sanchez M., et al. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol 2010, 42(1):32-39.
2. Ma J., Chen T., Mandelin J., et al. Regulation of macrophage activation. Cell Mol Life Sci 2003, 60(11):2334-2346.
3. Robbins S.L., Kumar V., Cotran R.S. Robbins and Cotran pathologic basis of disease 2010, Saunders/Elsevier, Philadelphia, p. 1450, xiv. 8th edition.
4. Co D.O., Hogan L.H., Il-Kim S., et al. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004, 92(1-2):135-142.
5. Wallis R.S., Ehlers S. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 2005, 34(5 Suppl 1):34-38.
6. Schoppet M., Pankuweit S., Maisch B. Cardiac sarcoidosis: cytokine patterns in the course of the disease. Arch Pathol Lab Med 2003, 127(9):1207-1210.
7. Lefkowitch J.H. Hepatic granulomas. J Hepatol 1999, 30(Suppl 1):40-45.
8. Satti M.B., al-Freihi H., Ibrahim E.M., et al. Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am J Gastroenterol 1990, 85(6):669-674.
9. Sanai F.M., Ashraf S., Abdo A.A., et al. Hepatic granuloma: decreasing trend in a high-incidence area. Liver Int 2008, 28(10):1402-1407.
10. Gaya D.R., Thorburn D., Oien K.A., et al. Hepatic granulomas: a 10 year single centre experience. J Clin Pathol 2003, 56(11):850-853.
11. McCluggage W.G., Sloan J.M. Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology 1994, 25(3):219-228.
12. Drebber U., Kasper H.U., Ratering J., et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis-a study of 442 cases. Liver Int 2008, 28(6):828-834.
13. Dourakis S.P., Saramadou R., Alexopoulou A., et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol 2007, 19(2):101-104.
14. Martin-Blondel G., Camara B., Selves J., et al. Rev Med Interne 2010, 31(2):97-106. [in French].
15. Gershwin M.E., Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008, 47(2):737-745.
16. Myers R.P., Shaheen A.A., Fong A., et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology 2009, 50(10):1-9.
17. Lleo A., Invernizzi P., Mackay I.R., et al. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol 2008, 14(21):3328-3337.
18. Drebber U., Mueller J.J., Klein E., et al. Liver biopsy in primary biliary cirrhosis: clinicopathological data and stage. Pathol Int 2009, 59(8):546-554.
19. Rybicki B.A., Iannuzzi M.C. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 2007, 28(1):22-35.
20. Doughan A.R., Williams B.R. Cardiac sarcoidosis. Heart 2006, 92:282-288.
21. Ayyala U.S., Padilla M.L. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol 2006, 9(6):475-483.
22. Ebert E.C., Kierson M., Hagspiel K.D. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008, 103(12):3184-3192. [quiz 3193].
23. Roberts W.C., McAllister H.A., Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977, 63(1):86-108.
24. Moreno-Merlo F., Wanless I.R., Shimamatsu K., et al. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997, 26(3):554-560.
25. Mueller S., Boehme M.W., Hofmann W.J., et al. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol 2000, 35(9):1003-1008.
26. Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007, 28(1):36-52.
27. Ishak K.G. Sarcoidosis of the liver and bile ducts. Mayo Clin Proc 1998, 73(5):467-472.
28. Hsu R.M., Connors A.F., Tomashefski J.F. Histologic, microbiologic, and clinical correlates of the diagnosis of sarcoidosis by transbronchial biopsy. Arch Pathol Lab Med 1996, 120(4):364-368.
29. Jones Williams W. The nature and origin of Schaumann bodies. J Pathol Bacteriol 1960, 79:193-201.
30. Devaney K., Goodman Z.D., Epstein M.S., et al. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993, 17(12):1272-1280.
31. Scheuer P.J. Hepatic granulomas. Br Med J (Clin Res Ed) 1982, 285(6345):833-834.
32. Miller E.B., Shichmanter R., Friedman J.A., et al. Granulomatous hepatitis and Sjogren's syndrome: an association. Semin Arthritis Rheum 2006, 36(3):153-158.
33. Ferrell L.D., Lee R., Brixko C., et al. Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients. Transplantation 1995, 60(9):926-933.
34. Odze R.D., Goldblum J.R., Crawford J.M. Surgical pathology of the GI tract, liver, biliary tract, and pancreas 2004, Saunders, Philadelphia, p. 1067.
35. Vakiani E., Hunt K.K., Mazziotta R.M., et al. Hepatitis C-associated granulomas after liver transplantation: morphologic spectrum and clinical implications. Am J Clin Pathol 2007, 127(1):128-134.
36. Lamps L.W. Hepatic granulomas, with an emphasis on infectious causes. Adv Anat Pathol 2008, 15(6):309-318.
37. Emile J.F., Sebagh M., Féray C., et al. The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis. Hum Pathol 1993, 24(10):1095-1097.
38. Ozaras R., Tahan V., Mert A., et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 2004, 38(5):449-452.
39. Snyder N., Martinez J.G., Xiao S.Y. Chronic hepatitis C is a common associated with hepatic granulomas. World J Gastroenterol 2008, 14(41):6366-6369.
40. Fiel M.I., Shukla D., Saraf N., et al. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transpl Infect Dis 2008, 10(3):184-189.
41. Kanno A., Murakami K. A transient emergence of hepatic granulomas in a patient with chronic hepatitis B. Tohoku J Exp Med 1998, 185(4):281-285.
42. Goldin R.D., Levine T.S., Foster G.R., et al. Granulomas and hepatitis C. Histopathology 1996, 28(3):265-267.
43. Tahan V., Ozaras R., Lacevic N., et al. Prevalence of hepatic granulomas in chronic hepatitis B. Dig Dis Sci 2004, 49(10):1575-1577.
44. Hayashi M., Yamawaki I., Okajima K., et al. Tuberculous liver abscess not associated with lung involvement. Intern Med 2004, 43(6):521-523.
45. Bratton R.L., Whiteside J.W., Hovan M.J., et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc 2008, 83(5):566-571.
46. Zanchi A.C., Gingold A.R., Theise N.D., et al. Necrotizing granulomatous hepatitis as an unusual manifestation of Lyme disease. Dig Dis Sci 2007, 52(10):2629-2632.
47. Wong P., Houston S., Power B., et al. A case of Histoplasma capsulatum causing granulomatous liver disease and Addisonian crisis. Can J Gastroenterol 2001, 15(10):687-691.
48. Mert A., Tabak F., Ozaras R., et al. Typhoid fever as a rare cause of hepatic, splenic, and bone marrow granulomas. Intern Med 2004, 43(5):436-439.
49. Mentink-Kane M.M., Cheever A.W., Thompson R.W., et al. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A 2004, 101(2):586-590.
50. Chiaramonte M.G., Donaldson D.D., Cheever A.W., et al. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999, 104(6):777-785.
51. Ishak K.G., Zimmerman H.J. Drug-induced and toxic granulomatous hepatitis. Baillieres Clin Gastroenterol 1986, 2:463-480.
52. Farah M., Al Rashidi A., Owen D.A., et al. Granulomatous hepatitis associated with etanercept therapy. J Rheumatol 2008, 35(2):349-351.
53. Sartin J.S., Walker R.C. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo clinic. Mayo Clin Proc 1991, 66(9):914-918.
54. Sarachek N.S., London R.L., Matulewicz T.J. Diltiazem and granulomatous hepatitis. Gastroenterology 1985, 88(5 Pt 1):1260-1262.
55. Mifuji R., Iwasa M., Tanaka Y., et al. " Green juice" -associated granulomatous hepatitis. Am J Gastroenterol 2003, 98(10):2334-2335.
56. Dhawan M., Agrawal R., Ravi J., et al. Rosiglitazone-induced granulomatous hepatitis. J Clin Gastroenterol 2002, 34(5):582-584.
57. Braun M., Fraser G.M., Kunin M., et al. Mesalamine-induced granulomatous hepatitis. Am J Gastroenterol 1999, 94(7):1973-1974.
58. Liaw Y.F., Huang M.J., Fan K.D., et al. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med 1993, 118(6):424-428.
59. Abe M., Kumagi T., Nakanishi S., et al. Drug-induced hepatitis with hepatic granuloma due to saridon. J Gastroenterol 2002, 37(12):1068-1072.
60. Hussain H., Black M. Granulomatous liver disease. Curr Treat Options Gastroenterol 2000, 3(6):473-480.
61. Harrington P.T., Guiterrez J.J., Ramirez-Ronda C.H., et al. Granulomatous hepatitis. Rev Infect Dis 1982, 4(3):638-655.